Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

EM Systems

DB:EMO
Snowflake Description

Excellent balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EMO
DB
¥62B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

EM Systems Co., Ltd. develops, sells, and maintains computer software for medical business processing and dispensing business processing in Japan. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
EMO Share Price and Events
7 Day Returns
-2%
DB:EMO
16.8%
DE Healthcare Services
2.1%
DE Market
1 Year Returns
41.2%
DB:EMO
15.8%
DE Healthcare Services
-16.6%
DE Market
EMO Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
EM Systems (EMO) -2% 6.6% -8.8% 41.2% 97.2% 309.3%
DE Healthcare Services 16.8% 4.4% -1.9% 15.8% 50.3% 117%
DE Market 2.1% -12.6% -22.9% -16.6% -21.9% -27.8%
1 Year Return vs Industry and Market
  • EMO outperformed the Healthcare Services industry which returned 15.8% over the past year.
  • EMO outperformed the Market in Germany which returned -16.6% over the past year.
Price Volatility
EMO
Industry
5yr Volatility vs Market
Related Companies

EMO Value

 Is EM Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of EM Systems to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for EM Systems.

DB:EMO Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:EMO
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 6.3%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.79
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.794 (1 + (1- 30.86%) (0.19%))
0.862
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.86
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.862 * 6.33%)
5.07%

Discounted Cash Flow Calculation for DB:EMO using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for EM Systems is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:EMO DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (JPY, Millions) Source Present Value
Discounted (@ 5.07%)
2020 1,133.00 Analyst x1 1,078.34
2021 1,612.00 Analyst x1 1,460.20
2022 1,981.00 Analyst x1 1,707.88
2023 2,558.00 Analyst x1 2,098.92
2024 3,352.00 Analyst x1 2,617.73
2025 3,942.00 Analyst x1 2,929.96
2026 4,348.33 Est @ 10.31% 3,076.03
2027 4,656.99 Est @ 7.1% 3,135.43
2028 4,882.94 Est @ 4.85% 3,128.94
2029 5,043.06 Est @ 3.28% 3,075.64
Present value of next 10 years cash flows ¥24,309.00
DB:EMO DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= ¥5,043.06 × (1 + -0.39%) ÷ (5.07% – -0.39%)
¥92,014.91
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ¥92,014.91 ÷ (1 + 5.07%)10
¥56,117.55
DB:EMO Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ¥24,309.00 + ¥56,117.55
¥80,426.55
Equity Value per Share
(JPY)
= Total value / Shares Outstanding
= ¥80,426.55 / 70.84
¥1135.3
DB:EMO Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:EMO represents 0.00826x of TSE:4820
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.00826x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (JPY) x Listing Adjustment Factor
= ¥ 1,135.30 x 0.00826
€9.37
Value per share (EUR) From above. €9.37
Current discount Discount to share price of €7.25
= -1 x (€7.25 - €9.37) / €9.37
22.7%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price EM Systems is available for.
Intrinsic value
23%
Share price is €7.25 vs Future cash flow value of €9.37
Current Discount Checks
For EM Systems to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • EM Systems's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • EM Systems's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for EM Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are EM Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:EMO PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in JPY ¥20.82
TSE:4820 Share Price ** TSE (2020-04-07) in JPY ¥878
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.51x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 16.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of EM Systems.

DB:EMO PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSE:4820 Share Price ÷ EPS (both in JPY)

= 878 ÷ 20.82

42.16x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EM Systems is overvalued based on earnings compared to the DE Healthcare Services industry average.
  • EM Systems is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does EM Systems's expected growth come at a high price?
Raw Data
DB:EMO PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 42.16x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
22.1%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.68x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

DB:EMO PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 42.16x ÷ 22.1%

1.91x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EM Systems is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on EM Systems's assets?
Raw Data
DB:EMO PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in JPY ¥243.59
TSE:4820 Share Price * TSE (2020-04-07) in JPY ¥878
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.82x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.45x
DB:EMO PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSE:4820 Share Price ÷ Book Value per Share (both in JPY)

= 878 ÷ 243.59

3.6x

* Primary Listing of EM Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EM Systems is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess EM Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. EM Systems has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EMO Future Performance

 How is EM Systems expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
22.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is EM Systems expected to grow at an attractive rate?
  • EM Systems's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • EM Systems's earnings growth is expected to exceed the Germany market average.
  • EM Systems's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:EMO Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:EMO Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 22.1%
DB:EMO Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 11.2%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:EMO Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in JPY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:EMO Future Estimates Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2025-03-31
2024-03-31 21,600 3,870 3,600 1
2023-03-31 18,800 3,877 2,800 1
2022-03-31 15,950 2,535 2,330 2
2021-03-31 14,300 2,130 1,697 2
2020-04-07
2020-03-31 13,475 1,307 1,491 2
DB:EMO Past Financials Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income *
2019-12-31 13,826 1,467
2019-09-30 13,625 2,148 1,636
2019-06-30 13,225 1,873
2019-03-31 13,133 1,846 1,971
2018-12-31 13,122 2,183
2018-09-30 13,674 2,640 2,352
2018-06-30 14,032 2,441
2018-03-31 13,953 2,324 2,369
2017-12-31 14,281 2,541
2017-09-30 14,027 2,159 2,373
2017-06-30 13,764 2,172
2017-03-31 13,676 2,080 2,116

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • EM Systems's earnings are expected to grow significantly at over 20% yearly.
  • EM Systems's revenue is expected to grow by 11.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:EMO Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from EM Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:EMO Future Estimates Data
Date (Data in JPY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2025-03-31
2024-03-31 50.90 50.90 50.90 1.00
2023-03-31 39.60 39.60 39.60 1.00
2022-03-31 32.20 34.70 29.70 2.00
2021-03-31 23.45 23.90 23.00 2.00
2020-04-07
2020-03-31 20.65 21.20 20.10 2.00
DB:EMO Past Financials Data
Date (Data in JPY Millions) EPS *
2019-12-31 20.82
2019-09-30 23.21
2019-06-30 26.55
2019-03-31 27.86
2018-12-31 30.77
2018-09-30 33.13
2018-06-30 34.33
2018-03-31 33.35
2017-12-31 35.86
2017-09-30 33.58
2017-06-30 30.84
2017-03-31 30.15

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • EM Systems is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess EM Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
EM Systems has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EMO Past Performance

  How has EM Systems performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare EM Systems's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • EM Systems's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • EM Systems's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • EM Systems's 1-year earnings growth is negative, it can't be compared to the DE Healthcare Services industry average.
Earnings and Revenue History
EM Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from EM Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:EMO Past Revenue, Cash Flow and Net Income Data
Date (Data in JPY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 13,826.00 1,467.00 5,073.00 13.00
2019-09-30 13,625.00 1,636.00 4,879.00 13.00
2019-06-30 13,225.00 1,873.00 4,641.00 13.00
2019-03-31 13,133.00 1,971.00 4,533.00 13.00
2018-12-31 13,122.00 2,183.00 4,407.00 42.00
2018-09-30 13,674.00 2,352.00 4,414.00 42.00
2018-06-30 14,032.00 2,441.00 4,408.00 42.00
2018-03-31 13,953.00 2,369.00 4,479.00 42.00
2017-12-31 14,281.00 2,541.00 4,575.00 34.00
2017-09-30 14,027.00 2,373.00 4,625.00 34.00
2017-06-30 13,764.00 2,172.00 4,764.00 34.00
2017-03-31 13,676.00 2,116.00 4,763.00 34.00
2016-12-31 13,545.00 1,855.00 4,689.00
2016-09-30 13,472.00 1,773.00 4,784.00
2016-06-30 13,456.00 1,705.00 4,709.00
2016-03-31 13,199.00 1,621.00 4,837.00
2015-12-31 12,890.00 1,627.00 4,821.00 1.00
2015-09-30 12,374.00 1,392.00 4,832.00 1.00
2015-06-30 11,586.00 1,226.00 4,762.00 1.00
2015-03-31 11,257.00 965.00 4,711.00 1.00
2014-12-31 11,386.00 1,054.00 4,811.00 18.00
2014-09-30 11,553.00 1,218.00 4,751.00 18.00
2014-06-30 11,652.00 1,378.00 4,580.00 18.00
2014-03-31 11,369.00 1,420.00 4,375.00 18.00
2013-12-31 10,865.00 1,398.00 4,119.00 29.00
2013-09-30 10,266.00 1,242.00 3,908.00 29.00
2013-06-30 10,068.00 1,056.00 3,942.00 29.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • EM Systems has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • EM Systems used its assets less efficiently than the DE Healthcare Services industry average last year based on Return on Assets.
  • EM Systems's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess EM Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
EM Systems has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EMO Health

 How is EM Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up EM Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • EM Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • EM Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of EM Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 181x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from EM Systems Company Filings, last reported 3 months ago.

DB:EMO Past Debt and Equity Data
Date (Data in JPY Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 17,237.00 60.00 7,776.00
2019-09-30 17,151.00 85.00 8,159.00
2019-06-30 16,673.00 112.00 7,231.00
2019-03-31 16,618.00 138.00 7,487.00
2018-12-31 16,717.00 231.00 7,735.00
2018-09-30 16,479.00 360.00 8,376.00
2018-06-30 16,099.00 507.00 7,989.00
2018-03-31 16,052.00 654.00 8,528.00
2017-12-31 15,442.00 802.00 7,172.00
2017-09-30 15,013.00 948.00 7,246.00
2017-06-30 14,235.00 1,095.00 6,532.00
2017-03-31 14,064.00 2,081.00 7,901.00
2016-12-31 13,325.00 2,213.00 6,385.00
2016-09-30 12,946.00 2,544.00 6,502.00
2016-06-30 12,365.00 2,706.00 5,756.00
2016-03-31 12,172.00 2,868.00 6,354.00
2015-12-31 11,782.00 3,047.00 3,815.00
2015-09-30 11,493.00 3,276.00 4,733.00
2015-06-30 11,024.00 3,484.00 4,482.00
2015-03-31 11,011.00 3,658.00 5,039.00
2014-12-31 9,443.00 3,830.00 2,833.00
2014-09-30 9,366.00 3,862.00 3,005.00
2014-06-30 9,081.00 4,027.00 2,655.00
2014-03-31 9,204.00 4,192.00 2,985.00
2013-12-31 8,196.00 4,357.00 1,853.00
2013-09-30 7,943.00 4,622.00 1,975.00
2013-06-30 7,493.00 4,276.00 1,415.00
  • EM Systems's level of debt (0.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (40.5% vs 0.3% today).
  • Debt is well covered by operating cash flow (3580%, greater than 20% of total debt).
  • Unable to confirm if the interest payments on EM Systems's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess EM Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. EM Systems has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EMO Dividends

 What is EM Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.08%
Current annual income from EM Systems dividends. Estimated to be 1.65% next year.
If you bought €2,000 of EM Systems shares you are expected to receive €22 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • EM Systems's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.67%).
  • EM Systems's dividend is below the markets top 25% of dividend payers in Germany (4.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:EMO Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.7%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:EMO Future Dividends Estimate Data
Date (Data in ¥) Dividend per Share (annual) Avg. No. Analysts
2025-03-31
2024-03-31 20.00 1.00
2023-03-31 16.00 1.00
2022-03-31 12.00 1.00
2021-03-31 10.00 1.00
2020-04-07
2020-03-31 9.50 1.00
DB:EMO Past Annualized Dividends Data
Date (Data in ¥) Dividend per share (annual) Avg. Yield (%)
2019-06-19 9.500 1.030
2019-05-08 9.500 1.240
2018-06-19 9.000 1.510
2018-05-08 9.000 1.660
2018-02-13 9.250 1.443
2018-02-09 9.250 1.577
2017-11-10 8.250 1.331
2017-06-20 7.750 1.366
2017-05-09 7.750 1.441
2016-06-28 6.250 1.604
2016-05-13 6.250 2.055
2015-11-06 5.875 1.906
2015-06-26 5.625 2.062
2015-05-13 5.875 2.114
2014-08-06 5.625 2.561
2014-06-27 5.625 2.510
2014-05-13 5.625 2.513
2013-06-27 3.750 1.460
2013-05-13 3.750 1.529
2013-02-13 2.500 1.189
2013-02-08 1.250 0.595
2012-11-13 2.500 1.099
2012-11-06 1.875 0.741
2012-06-28 2.625 1.297
2012-05-14 2.625 1.300
2011-06-29 2.250 1.831
2011-05-13 2.250 2.368
2010-06-29 1.625 2.066
2010-05-14 1.625 2.089
2009-06-26 1.625 2.581
2009-05-15 1.625 2.340

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of EM Systems's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.2x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess EM Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can EM Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. EM Systems has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EMO Management

 What is the CEO of EM Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Kozo Kunimitsu
AGE 74
CEO Bio

Mr. Kozo Kunimitsu serves as the Chairman and Chief Executive Officer at EM Systems Co., Ltd. and served as its President since January 1980. Mr. Kunimitsu has been President of Yimeng Ruanjian Xitong Kaifa (Nanjing) Youxian Gongsi since June 2001. He served as President and Representative Director of Shokando Co., Ltd. since July 1997. He served as Chairman of Shokando Co., Ltd. since May 2003. He has been a Representative Director of EM Systems Co., Ltd., since January 1980. Mr. Kunimitsu served as Director at Honda Clio Sanyo K.K. since October 1970.

CEO Compensation
  • Insufficient data for Kozo to compare compensation growth.
  • Insufficient data for Kozo to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the EM Systems management team in years:

4.5
Average Tenure
58
Average Age
  • The tenure for the EM Systems management team is about average.
Management Team

Kozo Kunimitsu

TITLE
Chairman and Chief Executive Officer
AGE
74

Kenji Oishi

TITLE
President
AGE
61

Ryoko Mitsuhashi

TITLE
Senior Executive Officer & GM of Administrative Division
AGE
54
TENURE
5 yrs

Motoki Nishimura

TITLE
Managing Director
AGE
58
TENURE
4 yrs

Gen Aota

TITLE
Managing Director
AGE
57
TENURE
11.6 yrs

Nobuo Terauchi

TITLE
MD, Manager of Medical Care & Nursing Coordination Business Dept
AGE
61
TENURE
14 yrs

Hiromasa Kunimitsu

TITLE
Managing Director
AGE
45
TENURE
4 yrs

Hirokazu Kawanohara

TITLE
Senior Executive Officer and Overall Regional Sales Manager of Sales & Service Business Dept.
TENURE
0.8 yrs

Takeshi Shigeyama

TITLE
GM of Corporate Promotion Division & Senior Executive Officer

Shigeo Inoue

TITLE
Development GM of Pharmacy System Business Department & Senior Executive Officer
Board of Directors Tenure

Average tenure and age of the EM Systems board of directors in years:

7.8
Average Tenure
61
Average Age
  • The tenure for the EM Systems board of directors is about average.
Board of Directors

Kozo Kunimitsu

TITLE
Chairman and Chief Executive Officer
AGE
74

Kenji Oishi

TITLE
President
AGE
61

Motoki Nishimura

TITLE
Managing Director
AGE
58
TENURE
5.8 yrs

Gen Aota

TITLE
Managing Director
AGE
57
TENURE
10.8 yrs

Nobuo Terauchi

TITLE
MD, Manager of Medical Care & Nursing Coordination Business Dept
AGE
61

Hiromasa Kunimitsu

TITLE
Managing Director
AGE
45
TENURE
18.8 yrs

Hidetoshi Imaizumi

TITLE
Outside Director
AGE
75
TENURE
7.8 yrs

Shigemitsu Matsuda

TITLE
Outside Director
AGE
62
TENURE
7.8 yrs

Megumi Seki

TITLE
Full-Time Auditor
AGE
47
TENURE
8.8 yrs

Kozo Nobuhara

TITLE
External Auditor
TENURE
4.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess EM Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. EM Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EMO News

Simply Wall St News

EMO Company Info

Description

EM Systems Co., Ltd. develops, sells, and maintains computer software for medical business processing and dispensing business processing in Japan. It also develops, sells, and maintains computer software for nursing care providers; and provides medical information processing and information communication services. In addition, the company develops and sells computers and computer peripherals; and sells OA supplies and various products for medical institutions, as well as offers Aero shield, an ultraviolet sterilizer for air infection. Further, it develops and sells dispensing systems for pharmacies; network system, an application service provider dispensing support system; medical systems for clinics, including electronic medical record systems; and medical care cooperation solutions, as well as ASP services. Additionally, the company manages a sports gym, nursery school, conference room, and pharmacy. It also provides care systems; inkjet, medicine bag, and label printers; multifunction machines; and photo medicine bags. The company was founded in 1980 and is headquartered in Osaka, Japan.

Details
Name: EM Systems Co., Ltd.
EMO
Exchange: DB
Founded: 1980
¥527,567,889
70,841,730
Website: http://www.emsystems.co.jp
Address: EM Systems Co., Ltd.
Shin-Osaka Brick Building,
1-6-1 Miyahara,
Osaka,
532-0003,
Japan
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSE 4820 Common Shares The Tokyo Stock Exchange JP JPY 15. Dec 2000
DB EMO Common Shares Deutsche Boerse AG DE EUR 15. Dec 2000
Number of employees
Current staff
Staff numbers
581
EM Systems employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 23:22
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/03/12
Last earnings filing: 2020/02/13
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.